This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1538574408315995v1 42/2/101    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Pipinos, I. I. Articles by Dodd, S. L. Search for Related Content PubMed PubMed Citation Articles by Pipinos, I. I. Articles by Dodd, S. L. Pubmed/NCBI databases Medline Plus Health Information Muscle Disorders Peripheral Arterial Disease Social Bookmarking                         What's this?

The Myopathy of Peripheral Arterial Occlusive Disease: Part 2. Oxidative Stress, Neuropathy, and Shift in Muscle Fiber Type

^* To whom correspondence should be addressed. E-mail: ipipinos{at}unmc.edu.

	Abstract

In recent years, an increasing number of studies have demonstrated that a myopathy is present, contributes, and, to a certain extent, determines the pathogenesis of peripheral arterial occlusive disease. These works provide evidence that a state of repetitive cycles of exercise-induced ischemia followed by reperfusion at rest operates in patients with peripheral arterial occlusive disease and mediates a large number of structural and metabolic changes in the muscle, resulting in reduced strength and function. The key players in this process appear to be defective mitochondria that, through multilevel failure in their roles as energy, oxygen radical species, and apoptosis regulators, produce and sustain a progressive decline in muscle performance. In this 2-part review, the currently available evidence that characterizes the nature and mechanisms responsible for this myopathy is highlighted. In part 1, the functional and histomorphological characteristics of the myopathy were reviewed, and the main focus was on the biochemistry and bioenergetics of its mitochondriopathy. In part 2, accumulating evidence that oxidative stress related to ischemia reperfusion is probably the major operating mechanism of peripheral arterial occlusive disease myopathy is reviewed. Important new findings of a possible neuropathy and a shift in muscle fiber type are also reviewed. Learning more about these mechanisms will enhance our understanding of the degree to which they are preventable and treatable.

First published on April 7, 2008, doi:10.1177/1538574408315995

Vascular and Endovascular Surgery 2008;42:101.

A more recent version of this article appeared on May 1, 2008


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				L. Mascitelli, F. Pezzetta, M. R. Goldstein, and R. H. Samson Questioning the Safety of Life-long Statin Therapy in Patients With Peripheral Arterial Disease Vascular and Endovascular Surgery, February 1, 2009; 43(1): 109 - 111. [PDF]

				I. I. Pipinos, S. A. Swanson, Z. Zhu, A. A. Nella, D. J. Weiss, T. L. Gutti, R. D. McComb, B. T. Baxter, T. G. Lynch, and G. P. Casale Chronically ischemic mouse skeletal muscle exhibits myopathy in association with mitochondrial dysfunction and oxidative damage Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R290 - R296. [Abstract] [Full Text] [PDF]